GILD logo

Gilead Sciences (GILD) Cash from financing

annual CFF:

-$3.43B+$1.69B(+33.01%)
December 31, 2024

Summary

  • As of today (May 29, 2025), GILD annual cash flow from financing activities is -$3.43 billion, with the most recent change of +$1.69 billion (+33.01%) on December 31, 2024.
  • During the last 3 years, GILD annual CFF has risen by +$5.44 billion (+61.33%).
  • GILD annual CFF is now -201.18% below its all-time high of $3.39 billion, reached on December 31, 2017.

Performance

GILD Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDcash flow metrics

quarterly CFF:

-$3.43B-$5.69B(-251.59%)
March 1, 2025

Summary

  • As of today (May 29, 2025), GILD quarterly cash flow from financing activities is -$3.43 billion, with the most recent change of -$5.69 billion (-251.59%) on March 1, 2025.
  • Over the past year, GILD quarterly CFF has dropped by -$2.06 billion (-151.73%).
  • GILD quarterly CFF is now -151.57% below its all-time high of $6.64 billion, reached on September 30, 2015.

Performance

GILD quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDcash flow metrics

TTM CFF:

-$5.50B-$2.06B(-60.15%)
March 1, 2025

Summary

  • As of today (May 29, 2025), GILD TTM cash flow from financing activities is -$5.50 billion, with the most recent change of -$2.06 billion (-60.15%) on March 1, 2025.
  • Over the past year, GILD TTM CFF has dropped by -$418.00 million (-8.23%).
  • GILD TTM CFF is now -219.53% below its all-time high of $4.60 billion, reached on September 30, 2012.

Performance

GILD TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GILD Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+33.0%-151.7%-8.2%
3 y3 years+61.3%-91.0%+32.9%
5 y5 years+55.0%-31.2%+30.2%

GILD Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+61.3%-251.6%at low-60.1%+33.5%
5 y5-year-545.8%+61.3%-183.1%+2.9%-708.2%+38.1%
alltimeall time-201.2%+72.1%-151.6%+60.2%-219.5%+56.4%

GILD Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$3.43B(-251.6%)
-$5.50B(+60.2%)
Dec 2024
-$3.43B(-33.0%)
$2.26B(-263.9%)
-$3.43B(-49.5%)
Sep 2024
-
-$1.38B(-53.3%)
-$6.79B(-2.0%)
Jun 2024
-
-$2.95B(+117.0%)
-$6.93B(+36.5%)
Mar 2024
-
-$1.36B(+23.8%)
-$5.08B(-0.9%)
Dec 2023
-$5.13B(-20.8%)
-$1.10B(-27.6%)
-$5.13B(-8.2%)
Sep 2023
-
-$1.52B(+38.0%)
-$5.58B(-9.7%)
Jun 2023
-
-$1.10B(-21.7%)
-$6.18B(+1.6%)
Mar 2023
-
-$1.41B(-9.5%)
-$6.08B(-6.0%)
Dec 2022
-$6.47B(-27.1%)
-$1.55B(-26.6%)
-$6.47B(-5.7%)
Sep 2022
-
-$2.12B(+111.2%)
-$6.86B(-17.0%)
Jun 2022
-
-$1.00B(-44.1%)
-$8.27B(+0.9%)
Mar 2022
-
-$1.79B(-7.6%)
-$8.19B(-7.7%)
Dec 2021
-$8.88B(-1252.9%)
-$1.94B(-44.9%)
-$8.88B(+30.5%)
Sep 2021
-
-$3.53B(+278.8%)
-$6.80B(-903.3%)
Jun 2021
-
-$931.00M(-62.4%)
$847.00M(-6.3%)
Mar 2021
-
-$2.48B(-1990.8%)
$904.00M(+17.4%)
Dec 2020
$770.00M(-110.1%)
$131.00M(-96.8%)
$770.00M(-399.6%)
Sep 2020
-
$4.12B(-571.9%)
-$257.00M(-96.3%)
Jun 2020
-
-$874.00M(-66.5%)
-$6.90B(-12.5%)
Mar 2020
-
-$2.61B(+191.4%)
-$7.88B(+3.2%)
Dec 2019
-$7.63B(-38.0%)
-$896.00M(-64.4%)
-$7.63B(-9.2%)
Sep 2019
-
-$2.52B(+35.4%)
-$8.41B(-4.4%)
Jun 2019
-
-$1.86B(-21.5%)
-$8.79B(+8.7%)
Mar 2019
-
-$2.37B(+41.7%)
-$8.09B(-34.3%)
Dec 2018
-$12.32B(-463.0%)
-$1.67B(-42.4%)
-$12.32B(+68.7%)
Sep 2018
-
-$2.90B(+151.8%)
-$7.30B(+227.4%)
Jun 2018
-
-$1.15B(-82.5%)
-$2.23B(+13.9%)
Mar 2018
-
-$6.59B(-297.0%)
-$1.96B(-157.7%)
Dec 2017
$3.39B(-134.9%)
$3.35B(+54.2%)
$3.39B(-247.4%)
Sep 2017
-
$2.17B(-346.6%)
-$2.30B(+37.4%)
Jun 2017
-
-$880.00M(-29.3%)
-$1.68B(-28.9%)
Mar 2017
-
-$1.24B(-47.0%)
-$2.36B(-75.8%)
Dec 2016
-$9.72B(+65.3%)
-$2.35B(-183.9%)
-$9.72B(-17.9%)
Sep 2016
-
$2.80B(-279.2%)
-$11.84B(+48.1%)
Jun 2016
-
-$1.56B(-81.9%)
-$8.00B(-32.1%)
Mar 2016
-
-$8.61B(+92.9%)
-$11.78B(+100.1%)
Dec 2015
-$5.88B(+94.5%)
-$4.46B(-167.2%)
-$5.88B(+3080.5%)
Sep 2015
-
$6.64B(-224.4%)
-$185.00M(-98.5%)
Jun 2015
-
-$5.34B(+96.2%)
-$12.60B(+46.0%)
Mar 2015
-
-$2.72B(-320.6%)
-$8.63B(+185.3%)
Dec 2014
-$3.02B(+18.9%)
$1.23B(-121.4%)
-$3.02B(-40.7%)
Sep 2014
-
-$5.77B(+321.0%)
-$5.10B(+1760.4%)
Jun 2014
-
-$1.37B(-147.5%)
-$274.35M(-150.9%)
Mar 2014
-
$2.88B(-441.3%)
$539.00M(-121.2%)
Dec 2013
-$2.54B(-551.9%)
-$845.12M(-10.3%)
-$2.54B(+15.2%)
Sep 2013
-
-$942.23M(+69.0%)
-$2.21B(+40.3%)
Jun 2013
-
-$557.65M(+180.2%)
-$1.57B(+5.5%)
Mar 2013
-
-$199.00M(-61.0%)
-$1.49B(-364.9%)
Dec 2012
$563.00M(-68.1%)
-$510.20M(+65.9%)
$563.00M(-87.8%)
Sep 2012
-
-$307.51M(-35.2%)
$4.60B(+14.1%)
Jun 2012
-
-$474.88M(-125.6%)
$4.03B(+28.6%)
Mar 2012
-
$1.86B(-47.4%)
$3.13B(+77.7%)
Dec 2011
$1.76B(-231.7%)
$3.53B(-502.5%)
$1.76B(-179.3%)
Sep 2011
-
-$876.20M(-36.1%)
-$2.22B(+106.6%)
Jun 2011
-
-$1.37B(-382.8%)
-$1.08B(+23.7%)
Mar 2011
-
$485.11M(-205.5%)
-$869.63M(-35.0%)
Dec 2010
-$1.34B(+27.3%)
-$459.66M(-270.0%)
-$1.34B(+11.3%)
Sep 2010
-
$270.45M(-123.2%)
-$1.20B(-36.6%)
Jun 2010
-
-$1.17B(-7370.1%)
-$1.90B(+113.4%)
Mar 2010
-
$16.03M(-104.9%)
-$889.66M(-15.4%)
Dec 2009
-$1.05B(-28.7%)
-$324.08M(-23.8%)
-$1.05B(-20.0%)
Sep 2009
-
-$425.32M(+172.1%)
-$1.31B(+28.4%)
Jun 2009
-
-$156.29M(+7.2%)
-$1.02B(+10.0%)
Mar 2009
-
-$145.74M(-75.2%)
-$930.59M(-36.9%)
Dec 2008
-$1.47B
-$586.89M(+336.4%)
-$1.47B(+69.0%)
Sep 2008
-
-$134.49M(+111.9%)
-$872.34M(+27.6%)
DateAnnualQuarterlyTTM
Jun 2008
-
-$63.47M(-90.8%)
-$683.70M(-29.9%)
Mar 2008
-
-$689.72M(-4597.1%)
-$975.24M(+264.8%)
Dec 2007
-$267.30M(-141.2%)
$15.34M(-71.7%)
-$267.30M(+1.6%)
Sep 2007
-
$54.15M(-115.3%)
-$263.21M(-12.9%)
Jun 2007
-
-$355.01M(-2048.6%)
-$302.30M(-147.0%)
Mar 2007
-
$18.22M(-6.2%)
$642.70M(-1.0%)
Dec 2006
$649.26M(+46.9%)
$19.43M(+29.0%)
$649.26M(-32.7%)
Sep 2006
-
$15.06M(-97.4%)
$964.74M(-1.5%)
Jun 2006
-
$590.00M(+2281.2%)
$979.57M(+117.9%)
Mar 2006
-
$24.78M(-92.6%)
$449.52M(+1.7%)
Dec 2005
$441.90M(+461.8%)
$334.90M(+1020.6%)
$441.90M(+241.7%)
Sep 2005
-
$29.89M(-50.2%)
$129.33M(+11.4%)
Jun 2005
-
$59.95M(+249.6%)
$116.07M(+36.7%)
Mar 2005
-
$17.15M(-23.2%)
$84.92M(+8.0%)
Dec 2004
$78.66M(-4.2%)
$22.34M(+34.4%)
$78.66M(+12.2%)
Sep 2004
-
$16.62M(-42.3%)
$70.13M(-4.9%)
Jun 2004
-
$28.80M(+164.3%)
$73.72M(+7.8%)
Mar 2004
-
$10.89M(-21.1%)
$68.39M(-16.7%)
Dec 2003
$82.09M(-78.8%)
$13.81M(-31.7%)
$82.09M(-80.4%)
Sep 2003
-
$20.22M(-13.8%)
$417.85M(+3.1%)
Jun 2003
-
$23.46M(-4.6%)
$405.32M(+3.0%)
Mar 2003
-
$24.60M(-93.0%)
$393.42M(+1.8%)
Dec 2002
$386.61M(+1052.3%)
$349.57M(+4443.4%)
$386.61M(+619.2%)
Sep 2002
-
$7.69M(-33.4%)
$53.76M(+8.0%)
Jun 2002
-
$11.56M(-35.0%)
$49.78M(-0.3%)
Mar 2002
-
$17.79M(+6.4%)
$49.91M(+48.8%)
Dec 2001
$33.55M(-87.5%)
$16.72M(+349.4%)
$33.55M(-87.2%)
Sep 2001
-
$3.72M(-68.2%)
$261.77M(-2.6%)
Jun 2001
-
$11.69M(+721.4%)
$268.78M(+2.8%)
Mar 2001
-
$1.42M(-99.4%)
$261.38M(-2.8%)
Dec 2000
$269.05M(+1021.0%)
$244.94M(+2184.0%)
$269.05M(+896.3%)
Sep 2000
-
$10.72M(+149.5%)
$27.00M(+8.5%)
Jun 2000
-
$4.30M(-52.7%)
$24.89M(+2.6%)
Mar 2000
-
$9.08M(+213.2%)
$24.27M(+1.1%)
Dec 1999
$24.00M(+83.2%)
$2.90M(-66.3%)
$24.00M(+3.4%)
Sep 1999
-
$8.61M(+134.1%)
$23.20M(+7.9%)
Jun 1999
-
$3.68M(-58.3%)
$21.49M(+2.3%)
Mar 1999
-
$8.82M(+319.8%)
$21.02M(+60.4%)
Dec 1998
$13.10M(-88.3%)
$2.10M(-69.6%)
$13.10M(-82.9%)
Sep 1998
-
$6.90M(+115.6%)
$76.70M(+3.6%)
Jun 1998
-
$3.20M(+255.6%)
$74.00M(-33.9%)
Mar 1998
-
$900.00K(-98.6%)
$112.00M(-0.4%)
Dec 1997
$112.40M(-30.0%)
$65.70M(+1464.3%)
$112.40M(+122.6%)
Sep 1997
-
$4.20M(-89.8%)
$50.50M(+9.5%)
Jun 1997
-
$41.20M(+3069.2%)
$46.10M(+738.2%)
Mar 1997
-
$1.30M(-65.8%)
$5.50M(-96.6%)
Dec 1996
$160.60M(+78.4%)
$3.80M(-2000.0%)
$160.60M(+2.4%)
Sep 1996
-
-$200.00K(-133.3%)
$156.80M(-36.2%)
Jun 1996
-
$600.00K(-99.6%)
$245.90M(+0.1%)
Mar 1996
-
$156.40M(+75.9%)
$245.70M(+177.0%)
Dec 1995
$90.00M(+1566.7%)
-
-
Sep 1995
-
$88.90M(>+9900.0%)
$88.70M(<-9900.0%)
Jun 1995
-
$400.00K(-166.7%)
-$600.00K(-111.1%)
Mar 1995
-
-$600.00K(<-9900.0%)
$5.40M(-5.3%)
Mar 1995
$5.40M(+350.0%)
-
-
Dec 1994
-
$0.00(-100.0%)
$5.70M(-13.6%)
Sep 1994
-
-$400.00K(-106.3%)
$6.60M(-10.8%)
Jun 1994
-
$6.40M(-2233.3%)
$7.40M(+516.7%)
Mar 1994
$1.20M(-97.5%)
-$300.00K(-133.3%)
$1.20M(-84.2%)
Dec 1993
-
$900.00K(+125.0%)
$7.60M(-84.0%)
Sep 1993
-
$400.00K(+100.0%)
$47.50M(0.0%)
Jun 1993
-
$200.00K(-96.7%)
$47.50M(+0.6%)
Mar 1993
$47.20M(-52.5%)
$6.10M(-85.0%)
$47.20M(+14.8%)
Dec 1992
-
$40.80M(>+9900.0%)
$41.10M(>+9900.0%)
Sep 1992
-
$400.00K(-500.0%)
$300.00K(-400.0%)
Jun 1992
-
-$100.00K
-$100.00K
Mar 1992
$99.30M(+1189.6%)
-
-
Mar 1991
$7.70M
-
-

FAQ

  • What is Gilead Sciences annual cash flow from financing activities?
  • What is the all time high annual CFF for Gilead Sciences?
  • What is Gilead Sciences annual CFF year-on-year change?
  • What is Gilead Sciences quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Gilead Sciences?
  • What is Gilead Sciences quarterly CFF year-on-year change?
  • What is Gilead Sciences TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Gilead Sciences?
  • What is Gilead Sciences TTM CFF year-on-year change?

What is Gilead Sciences annual cash flow from financing activities?

The current annual CFF of GILD is -$3.43B

What is the all time high annual CFF for Gilead Sciences?

Gilead Sciences all-time high annual cash flow from financing activities is $3.39B

What is Gilead Sciences annual CFF year-on-year change?

Over the past year, GILD annual cash flow from financing activities has changed by +$1.69B (+33.01%)

What is Gilead Sciences quarterly cash flow from financing activities?

The current quarterly CFF of GILD is -$3.43B

What is the all time high quarterly CFF for Gilead Sciences?

Gilead Sciences all-time high quarterly cash flow from financing activities is $6.64B

What is Gilead Sciences quarterly CFF year-on-year change?

Over the past year, GILD quarterly cash flow from financing activities has changed by -$2.06B (-151.73%)

What is Gilead Sciences TTM cash flow from financing activities?

The current TTM CFF of GILD is -$5.50B

What is the all time high TTM CFF for Gilead Sciences?

Gilead Sciences all-time high TTM cash flow from financing activities is $4.60B

What is Gilead Sciences TTM CFF year-on-year change?

Over the past year, GILD TTM cash flow from financing activities has changed by -$418.00M (-8.23%)
On this page